Assessing the impact of Movalis [meloxicam] on health related quality of life

Trial Profile

Assessing the impact of Movalis [meloxicam] on health related quality of life

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Feb 2015

At a glance

  • Drugs Meloxicam (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 20 Nov 2009 Planned number of patients changed from 3531 to 3569, additional trial location identified as Croatia as reported by ClinicalTrials.gov.
    • 12 Feb 2009 Actual initiation date (Mar 2007) added as reported by ClinicalTrials.gov.
    • 12 Feb 2009 Planned number of patients changed from 4150 to 3531 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top